Powered by
Helix BioPharma sinks 4.3% - trailing 88% of stocks February 28, 2017 17:00 EST
Feb 28, 2017 - News Bites Canadian Markets


Helix BioPharma Corp. (TSX:HBP), Canada's 15th largest Biotechnology company by market cap, has sunk 6.0c (4.3%) from its last trading session of February 27 to close at CAD1.33. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price change was -3.8%. The volume was 0.6 times the average daily trading volume of 18,713 shares. In the Canadian market of 1,949 stocks and 84 units traded today, the stock has a 6-month relative

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox